Journal: The FASEB Journal
Article Title: ZXDB Drives Macrophage Inflammatory Programming in Sepsis‐Induced Acute Kidney Injury by Recruiting EIF4A3 to Enhance ACACA Translation
doi: 10.1096/fj.202502962RR
Figure Lengend Snippet: ZXDB is required for pro‐inflammatory macrophage activation and metabolic reprogramming. (A, B) Flow cytometric analysis of M1‐like (CD86 + INOS + ), M2a‐like (CD206 + ARG1 + ), and M2b‐like (CD86 + IL‐10 + ) surface markers on RAW264.7 (A) and THP‐1 (B) macrophages following stimulation with LPS (100 ng/mL) for 6 h, with or without Zxdb knockdown (shZxdb). Representative plots and quantification are shown. (C, D) Western blot analysis of key M1‐like (iNOS, CD40, CD86, CD80) and M2‐like (CD206, CD163, Arg1) protein markers in RAW264.7 (C) and THP‐1 (D) cells under the same conditions. GAPDH served as the loading control. (E, F) ELISA quantification of pro‐inflammatory (TNF‐α, IFN‐γ, IL‐1β) and anti‐inflammatory (IL‐10, IL‐4, IL‐13) cytokines secreted into the supernatant of RAW264.7 (E) and THP‐1 (F) cells. (G‐J) Assessment of metabolic state via relative lactate production (G, H) and intracellular ATP levels (I, J) in RAW264.7 and THP‐1 cells. p < 0.05, * p < 0.01, ** p < 0.001.
Article Snippet: Membranes were then incubated overnight at 4°C with primary antibodies against: ZXDB (A303‐656A; Invitrogen, 1:1000), ACACA (21923‐1‐AP; Proteintech, RRID:AB_11042445, 1:1000), EIF4A3 (17 504‐1‐AP; Proteintech, RRID:AB_2097393, 1:1000), iNOS (22226‐1‐AP; Proteintech, RRID:AB_2879038, 1:1000), CD86 (13395‐1‐AP; Proteintech–, RRID:AB_2074882, 1:1000), ARG1 (16001‐1‐AP; Proteintech–, RRID:AB_2289842, 1:1000), CD206 (18704‐1‐AP; Proteintech, RRID:AB_10597232, 1:1000), GAPDH (60004‐1‐Ig; Proteintech, RRID:AB_2107436, 1:10000).
Techniques: Activation Assay, Knockdown, Western Blot, Control, Enzyme-linked Immunosorbent Assay